6533b7dbfe1ef96bd12709f4

RESEARCH PRODUCT

MOESM1 of Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis

Agata Bielecka-dabrowaIbadete BytyรงiStephan HaehlingStefan AnkerJacek JozwiakJacek RyszAdrian HernandezGani BajraktariDimitri MikhalidisMaciej Banach

subject

nutritional and metabolic diseaseslipids (amino acids peptides and proteins)cardiovascular diseases

description

Additional file 1: Appendix 1. Assessment of risk of bias in the included studies using Cochrane criteria for RCTs. Appendix 2. Assessment of risk of bias in the included studies using Newcastle-Ottawa Quality Assessment Scale (NOS) for cohort studies. Figure S1. Association of statin versus non-statin use with all-cause mortality in heart failure only in cohort studies. Figure. S2. Association of statin versus non-statin use with CV mortality in heart failure only in cohort studies. Figure S3. Association of statin versus non-statin use hospitalization in heart failure only in cohort studies. Figure S4. Association of statin versus non-statin use with all-cause mortality by type of heart failure only in cohort studies. Figure S5. Association of statin versus non-statin use with CV mortality by type of heart failure only in cohort studies. Figure S6. Association of statin versus non-statin use with hospitalization by type of heart failure only in cohort studies. Table S1. Assessment of risk of bias in the included studies using Cochrane criteria for RCTs. Table S2. Assessment of risk of bias in the included studies using Newcastle-Ottawa Quality Assessment Scale (NOS) for cohort studies.

yearjournalcountryeditionlanguage
2019-01-01
https://dx.doi.org/10.6084/m9.figshare.10117160